Compare Mutual Funds
Select a Mutual Fund
Risk
Very High
-
Rating
5.0
-
Min SIP Amount
₹100
-
Expense Ratio
2
-
NAV
₹38.68
-
Fund Started
25 Jun 2018
-
Fund Size
₹6293.14 Cr
-
Exit Load
Exit load of 1% if redeemed within 15 days.
-
1 Year
4.68%
-
3 Year
25.92%
-
5 Year
15.59%
-
Equity
97.62%
-
Cash
2.35%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.11% |
Cipla Ltd. | 9.23% |
Mankind Pharma Ltd. | 7.01% |
Biocon Ltd. | 6.08% |
Dr. Reddy's Laboratories Ltd. | 5.97% |
Divi's Laboratories Ltd. | 5.91% |
Lupin Ltd. | 4.09% |
Alkem Laboratories Ltd. | 3.52% |
Syngene International Ltd. | 3.52% |
Aurobindo Pharma Ltd. | 3.30% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
-
Launch Date
25 Jun 2018
-
